Professor of Urology, University Miami School of Medicine
Urology
Dr. Angelo E. Gousse, MD
|
|
Give Review
Angelo Gousse works in the field of Urology. He studied medicine at Yale University School of Medicine. Yale University School of Medicine is one of the top medical schools in the US. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care He received awards:"Regional Top Doctor", "Meaningful Use Stage 1 Certification" and "Super Doctor". Angelo Gousse is also published. He has 69 publications published. The lastest publication: "4-Defect repair of grade 4 cystocele.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Mixed urinary incontinence: what first?
- Erratum to: OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity Regardless of Concomitant Anticholinergic Use...
- OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic E...
- Bladder Dysfunction in Patients with Diabetes.
- Repeat intradetrusor injections of onabotulinum toxin a for refractory idiopathic overactive Bladder patients: a single-center experience.
- Voiding Dysfunction in the female patient: is the "syndrome" paradigm valid?
- Role of botulinum toxin-A in refractory idiopathic overactive Bladder patients without detrusor overactivity.
- The challenges of iatrogenic proximal ureteric reconstruction.
- Urinary incontinence and pneumaturia: management and treatment.
- Urethrovaginal fistula repair.
- Medical management of stress urinary incontinence: is there a future?
- Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive Bladder: 100 versus 150 units.
- A historical perspective on cystocele repair--from honey to pessaries to anterior colporrhaphy: lessons from the past.
- Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence.
- Repeated botulinum toxin injection for idiopathic overactive Bladder: will chemodenervation become a long-term solution?
- Current techniques for vesicovaginal fistula repair: surgical pearls to optimize cure rate.
- Staging rectourinary fistulas to guide surgical treatment.
- Uronate peaks and urinary hyaluronic acid levels correlate with Interstitial cystitis severity.
- Female sexual Dysfunction following vaginal surgery: a review.
- Urinary uronate and sulfated glycosaminoglycan levels: markers for Interstitial cystitis severity.
- Two-stage management of severe postprostatectomy Bladder neck contracture associated with stress incontinence.
- Female sexual Dysfunction following vaginal surgery: myth or reality?
- Grade 4 cystocele repair using four-defect repair and porcine xenograft acellular matrix (Pelvicol): outcome measures using SEAPI.
- Missed bilateral Bladder perforation during pubovaginal sling procedure.
- Small bowel obstruction associated with tension-free vaginal tape.
- Intractable Chronic pelvic pain relieved after bone anchor removal.
- Complication of bowel perforation during insertion of tension-free vaginal tape.
- Pharmacological characterization of isolated human Prostate.
- Trichouria caused by ovarian teratoma with carcinoid elements.
- Value of express T2-weighted pelvic MRI in the preoperative evaluation of severe pelvic floor prolapse: a prospective study.
- Current practice patterns in the urologic surveillance and management of patients with spinal cord injury.
- What is the predictive value of urodynamics to reproduce clinical findings of urinary frequency, urge urinary incontinence, and/or stress urinary incontinence?
- The use of botulinum toxin a in idiopathic overactive Bladder syndrome.
- International standards to document remaining autonomic function after spinal cord injury.
- Predictors of response to intradetrusor botulinum toxin-A injections in patients with idiopathic overactive Bladder.
- The impact of lower urinary tract symptoms and urinary incontinence on female sexual Dysfunction using a validated instrument.
- Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection.
- Predictors of success for first stage neuromodulation: motor versus sensory response.
- Does postmenopausal hormone therapy cause urinary incontinence?
- [Female urethral Diverticulum. Report of a case].
- Management of neoBladder-vaginal fistula and stress incontinence following radical cystectomy in women: a review.
- Validation of a two-item quantitative questionnaire for the triage of women with urinary incontinence.
- Effect of insulin and dietary myoinositol on muscarinic receptor alterations in diabetic rat Bladder.
- Beta adrenergic receptor alterations in diabetic rat Prostate: effects of insulin and dietary myoinositol.
- Muscarinic receptors in diabetic rat Prostate.
- Genetic and molecular analysis of spontaneous respiratory deficient (res-) mutants of Escherichia coli K-12.
- Effects of experimental diabetes on biochemical and functional characteristics of Bladder muscarinic receptors.
- Diabetes-induced alterations in the properties of muscarinic cholinergic receptors in rat vas deferens.
- Primary Ewing's sarcoma of the Bladder associated with an elevated antinuclear antibody titer.
- Reconstruction and undiversion of the short or severely dilated ureter: the antireflux ileal nipple revisited.
- Tubulovillous adenoma in the cecal segment after cecocystoplasty.
- Refashioned short bowel segments for the construction of catheterizable channels (the Monti procedure): early clinical experience.
- Voiding Dysfunction in a mother and daughter with mitochondrial cytopathy.
- Primary human prostate Cancer cells harboring p53 mutations are clonally expanded in metastases.
- Association of p53 mutations with metastatic prostate Cancer.
- Bladder diverticula causing urinary retention in a woman without Bladder outlet obstruction.
- 4-Defect repair of grade 4 cystocele.
- Grading pelvic prolapse and pelvic floor relaxation using dynamic magnetic resonance imaging.
- Life-threatening anaphylactoid reaction associated with indigo carmine intravenous injection.
- Dynamic half Fourier acquisition, single shot turbo spin-echo magnetic resonance imaging for evaluating the female pelvis.
- Collaboration and practice patterns among urologists and gynecologists in the treatment of urinary incontinence and pelvic floor prolapse: a survey of the Internationa...
- [Acute urinary retention secondary to clear cell adenoCarcinoma of the urethra].
- Interposition flaps in transabdominal vesicovaginal fistula repairs: are they really necessary?
- Fixed and dynamic urethral compression for the treatment of post-Prostatectomy urinary incontinence: is history repeating itself?
- Artificial urinary sphincter for post-radical Prostatectomy urinary incontinence: long-term subjective results.
- Omental interposition for repair of a vesico-acetabular fistula.
- Postirradiation vesicovaginal fistula completely resolved with conservative treatment.
- Current investigations and treatment of Interstitial cystitis.
Schools
Yale University School Of Medicine
Baylor College Of Medicine
Procedures Preformed
- Cystometry
- Cystotomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Destruction or Excision of Vaginal Lesions
- View All
Conditions Treated
- Anemia
- Balanoposthitis
- Bladder Cancer
- Bladder Infection
- View All
Doctors Specialties
- Female Adult Urology
- Female Urology
- Male Adult Urology
- Neurological Urology
- Urologic Oncology
- Urologic Pathology
- Urologic Surgical Pathology
- Urology
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Baylor College of Medicine -
Yale University School of Medicine
Hospital
-
University of Miami Hospital
Drug Facts
| NPI NUMBER | 1821028259 | |
| NPPES Provider LastName | GOUSSE | |
| NPPES Provider FirstName | ANGELO | |
| NPPES Provider ZIPCode | 330295593 | |
| NPPES Provider State | FL | |
| Specialty Description | Urology | |
| Total Claim Count | 2796.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 92.0 | |
| Percent Opioid Claims | 3.29 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1821028259 |
| Last Name Of The Provider | GOUSSE |
| First Name Of The Provider | ANGELO |
| View All |
Similar Doctors
|
Dr. Michael A. Simon, MD |
|
Dr. Robert R. Kester, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Eliecer Kurzer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Matthew S. Fine, MD |